Why Aspen Aerogels is back in focus

Aspen Aerogels (ASPN) is back on investors’ radar after reporting a sharp year over year revenue decline, a large full year net loss, a sizeable impairment charge, and guidance indicating continued losses.

The stock’s recent swings reflect this reset in expectations, with a 7 day share price return showing a 13.57% decline and a 1 year total shareholder return indicating a 59% loss, highlighting how pressure has built over time.

If the volatility around Aspen Aerogels has you reassessing options, it could be a good moment to scan our screener of 23 power grid technology and infrastructure stocks for other ways to position around energy infrastructure themes.

With the share price down sharply, a value score of 5, and the stock trading below the latest analyst target of US$4.40, you have to ask: is this reset an entry point, or is the market already pricing in any future recovery?

Most Popular Narrative: 54.3% Undervalued

The most followed narrative on Aspen Aerogels sees a fair value of $6.83 per share versus the recent close at $3.12, framing the stock as materially undervalued and heavily tied to how its earnings story evolves.

Analysts are assuming Aspen Aerogels's revenue will grow by 8.9% annually over the next 3 years.

Analysts assume that profit margins will increase from 78.5% loss today to 12.3% profit in 3 years time.

If you want to see how those revenue and margin shifts attempt to justify a higher value, the full narrative spells out a detailed path from steep losses today to a very different earnings profile and a future valuation multiple that assumes Aspen Aerogels can eventually trade closer to established chemicals peers.

Result: Fair Value of $6.83 (UNDERVALUED)

However, higher 2025 loss guidance and heavy reliance on a few large EV and Energy Industrial customers could quickly challenge this undervalued thesis if projects or volumes slip.

Next Steps

With mixed signals across losses, guidance and valuation, this is the kind of story that rewards doing your own homework quickly. Check the full picture of risks and upsides in our breakdown of 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If Aspen Aerogels has you rethinking your watchlist, do not stop here. Use this moment to broaden your search and pressure test your next moves.

• Target resilient income by checking out 15 dividend fortresses that combine higher yields with a focus on staying power.
• Hunt for potential mispricing through our list of 46 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect them.
• Get ahead of the crowd by scanning a screener containing 24 high quality undiscovered gems before they land on everyone else’s radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.